You are here: Industry Insights > Pfizer

News List

US inks $1.95bn deal for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 23, 2020
The US Department of Health and Human Services (HHS) and the Department of Defense have executed an agreement valued at $1.95bn with Pfizer and BioNTech for up to 600 million doses of the companies’ Covid-19 vaccine candidate, BNT162.
UK Government secures early access to 90 million doses of COVID-19 vaccines europeanpharmaceuticalreview
July 21, 2020
The government has entered partnerships with Pfizer and Valneva to secure doses of several promising COVID-19 vaccines and secured COVID-19 neutralising antibody treatments from AstraZeneca.
UK enters supply agreement for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 21, 2020
The UK Government has signed an agreement with Pfizer and BioNTech for the supply of 30 million doses of the companies’ mRNA-based Covid-19 vaccine candidate, BNT162.
US fast tracks Pfizer/BioNTech coronavirus vaccines pharmatimes
July 17, 2020
US regulators have fast-tracked Pfizer and BioNTech's novel coronavirus vaccine candidates BNT162b1 and BNT162b2.
Pfizer commits $100m to support development of new antibiotics pharmaceutical-business-review
July 15, 2020
Major drugmaker Pfizer has committed $100m to the new Antimicrobial Resistance (AMR) Action Fund, which will support the development of new antibiotics due to increasing antibiotic-resistant infections.
FDA grants fast track status to Pfizer and BioNTech Covid-19 vaccines pharmaceutical-technology
July 15, 2020
Pfizer and BioNTech have received fast track designation from the US Food and Drug Administration (FDA) for two of their four potential Covid-19 vaccines.
Syneos Health, Pfizer Ink New Service Agreement contractpharma
July 14, 2020
Three-year agreement to provide global product development services to support Pfizer's portfolio.
Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’ status expresspharma
July 14, 2020
The market is “desperate to latch onto any positive developments in the vaccine field,” JP Morgan analyst Cory Kasimov said in a note.
Pfizer, BioNTech’s COVID-19 vaccine expected to be ready for approval by year end expresspharma
July 13, 2020
The experimental vaccine, which showed promise against the fast-spreading respiratory illness in early stage human testing, is expected to move into a large trial involving 30,000 healthy participants later this month.
Mylan Shareholders Approve Proposed Combination with Upjohn americanpharmaceuticalreview
July 10, 2020
Mylan announced its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a division of Pfizer, at the company's general meeting of shareholders.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page